Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%<blockquote>疫苗股早盘大涨Vir technology涨超15%Novavax涨超4%</blockquote>
These stocks are down at least 20% from 2021 highs, but Wall Street sees them gaining as much as 87% in 2022<blockquote>这些股票较2021年高点下跌至少20%,但华尔街预计2022年它们将上涨87%</blockquote>